Govt working on new pharma policy

Source: The Hindu Business Line, July 18, 2017

New Delhi: The Government is looking at introducing a new National Pharmaceuticals Policy and is already in the process of working out details, Parliament was informed on Tuesday. “The government is contemplating introducing a new National Pharmaceuticals Policy. The details are being worked out,” Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya told the Lok Sabha in a written reply.

Replying to a query on the time-frame for coming out with the new policy, he added: “No time limit can be indicated at this stage.”

 

Pharma market grows 7% in May, beats pre-GST fears

images.jpgSource: The Economic Times, June 10, 2017

MUMBAI: The organised pharma retail market witnessed a decent growth of over 7% in May, debunking fears of a slower growth with GST around the corner. In fact, the market continued with its trend of steady growth this year, starting in January with 10%, then 7% in February , nearly 10% in March, and 8.3% in April.The growth was buoyed by 10 therapies including gastrointestinal drugs, which outgrew the market, and anti-diabetic drugs showing strong double-digit growth.

Read the rest of this entry »

Japanese firm Rohto Pharma plans to expand base in India

Source: The Economic Times, May 31, 2017

MUMBAI: Japanese firm Rohto Pharmaceutical Co plans to expand its base in India with SastaSundar Healthbuddy Ltd as its preferred partner.

“We are looking for expansion of our base in India with SastaSundar as our preferred partner. We have invested USD 5 million (Rs 32 crore) to acquire 13 per cent stake in SastaSundar ,” Rohto Executive VP and Global Head of International Business Lekh Raj Juneja told reporters here.
Read the rest of this entry »

Pharmexcil working to boost exports to Africa

Source: The Hindu Business Line, Apr 27, 2017

Hyderabad: The Pharmaceutical Export Promotion Council (Pharmexcil) is working jointly with the Centre for harmonisation of export norms with African countries.

This was disclosed by its Chairman M Madan Mohan Reddy at a press conference, after the inauguration of the 5th edition of pharma expo, IPHEX 2017, here on Thursday.

Harmonisation of regulations will help pharma exporters by way of providing automatic approvals, among others.

Read the rest of this entry »

Govt’s generic push will dent Rs 90,000-cr branded pharma market

Source: Business Standard, Apr 24, 2017

New Delhi / Mumbai: Pharma companies may soon start wooing chemists as the Narendra Modi government plans to make it mandatory for doctors to prescribe pure-generic drugs, instead of branded generics as they do now.

Though the plan was first announced in this year’s Budget, the prime minister spoke about it for the first time at a public event on Monday. The health ministry has now started working on amending the Drugs and Cosmetics Act to this effect.“Indian patients may face quality issues without price benefit as intense competition among marketers will lead to incentivising a chemist,” says D G Shah, secretary-general of the Indian Pharmaceutical Alliance.

Read the rest of this entry »

Growth in Indian pharma exports revives in the third quarter

Source: Business Standard, Feb 27, 2017

Hyderabad: Indian pharma exports have increased 5.6 per cent to $4,357 million during October-December period in this financial year over the same quarter previous fiscal, as per the Pharmaceuticalsa Export Promotion Council (Pharmexcil) data.

The pharma body, which works under the Union Commerce Ministry, expects the rise in exports in the second half of this year to more than compensate for a marginal decline in the exports during April-October period. Read the rest of this entry »

Cadila, Cipla step up investments for improved drug quality

download.jpgSource: Business Standard, Feb 24, 2017

Mumbai: Drug makers including Cadila Healthcare and Cipla are investing in automation to enhance quality compliance and monitor deviations in manufacturing processes.

Investment in automation is one of the step undertaken by Indian companies who have come under the scanner of overseas drug regulators. Violations in good manufacturing practices have resulted in warning letters and delayed product approvals for Indian companies. To overcome this pharma companies are investing in both technology and staff training.

“We have invested around Rs 450 crore in automation and technology improvements. We have introduced laboratory information management system and a software which tracks deviations in manufacturing. We have also implemented electronic batch records system in our new plants in Ahmedabad SEZ and Vadodara and will be rolling out the electronic system in all other plants in next few years,” said Sharvil Patel, deputy managing director of Cadila Healthcare.

Read the rest of this entry »